GSK, Pfizer RSV Shots to Get Warning of Rare Neurological Disorder

Seeking Alpha06:30

Express News | The USA Food and Drug Administration (FDA): GlaxoSmithKline and Pfizer must issue warnings regarding their respiratory syncytial virus (RSV) vaccines. The RSV vaccines from these two companies may increase the risk of rare neurological side effects.

Breakings06:28

Arbutus Could Benefit From Big Pharma Bird Flu Vaccines: Jefferies

Seeking Alpha03:58

US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally

Benzinga00:56

J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)

TipRanks00:35 · Ratings

Moderna, Novavax and Other Vaccine Names Extend Gains Amid COVID/flu Concerns

Seeking Alpha00:12